(Q28294842)

English

Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine (English)

0 references

1 reference

1

Stewart J Tepper

0 references

author name string

Mark J Stillman

series ordinal

2

0 references

language of work or name

English

0 references

publication date

September 2008

0 references

1 reference

48

0 references

issue

8

0 references

page(s)

1259-68

0 references

cites work

Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2008.01214.X

retrieved

21 January 2018

Calcitonin gene-related peptide (CGRP) causes endothelium-dependent cyclic AMP, cyclic GMP and vasorelaxant responses in rat abdominal aorta

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0143-4179(91)90061-M

Identifiers

DOI

10.1111/J.1526-4610.2008.01214.X

0 references

PubMed publication ID

18808506

0 references

ResearchGate publication ID

23274330

0 references

(Q28294842)

Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)